 |
Market Research Report
Infectious Disease Diagnostics Market by Product & Solution (Consumables, System, Software & Services), Technology (Immunodiagnostics, PCR, INAAT), Disease (HIV, HAIS, Influenza), End User (Hospital, Reference Lab, Research)-Global Forecast to 2027 |
||||||
| Published by | Meticulous Market Research Pvt. Ltd. | Product code | 946874 | ||||
| Published | Content info | 200 Pages Delivery time: 1-2 business days |
|||||
| Price |
|
||||||
| Infectious Disease Diagnostics Market by Product & Solution (Consumables, System, Software & Services), Technology (Immunodiagnostics, PCR, INAAT), Disease (HIV, HAIS, Influenza), End User (Hospital, Reference Lab, Research)-Global Forecast to 2027 | ||
| Published: July 3, 2020 | Content info: 200 Pages |
|
Title:
Infectious Disease Diagnostics Market
by Product & Solution (Consumables, System, Software & Services), Technology (Immunodiagnostics, PCR, INAAT), Disease (HIV, HAIS, Influenza), End User (Hospital, Reference Lab, Research) - Forecast to 2027.
The infectious disease diagnostics market is expected to grow at a CAGR of 7.4% from 2020 to 2027 to reach $23.17 billion by 2027.
Succeeding an extensive secondary and primary research and in-depth analysis of the market scenario, the report carries out the in-depth analysis on key industry drivers, restraints, challenges, and opportunities. The growth in the infectious disease diagnostics market is mainly attributed to the increasing global prevalence of infectious diseases such as COVID-19, Ebola, and Swine Flu, among others; growing awareness for early detection using specific diagnostic tests; growth in funding for research on infectious disease diagnostics; and shift in focus from centralized laboratories to decentralized point-of-care testing services. Moreover, advances in genomics and proteomics and emerging countries provide increasing growth opportunities for players operating in the infectious disease diagnostics market.
The infectious disease diagnostics market study presents historical market data in terms of value (2018, and 2019), estimated current data (2020), and forecasts for 2027 - by product & solution, technology, disease type, and end user. The study also evaluates industry competitors and analyzes the market at regional and country level.
Based on products & solutions, the consumables segment is estimated to hold the largest share of the overall infectious disease diagnostics market in 2020. The large share of this segment is mainly attributed to the increasing prevalence of infectious diseases, rising awareness among the population to identify the diseases, and increasing use of kits and reagents to identify the organism causing various diseases in lesser time and cost.
On the basis of technology, the immunodiagnostics segment is estimated to account for the largest share of the overall infectious disease diagnostics market in 2020. Increasing use of immunoassays in infectious disease testing, development of novel tests, rising trend of automation, increasing awareness about the health and fitness, and reduced complications associated with the instruments are some of the major factors driving the growth of this market.
On the basis of disease type, the hepatitis diseases segment is estimated to hold the largest share of the overall infectious disease diagnostics market in 2020. Increasing number of blood transfusions and donations, increasing prevalence of hepatitis B & C infections, rising susceptibility of the geriatric population, growing awareness among the population, and benefits offered by point of care instruments & kits are expected to propel the growth of this segment.
An in-depth analysis of the geographical scenario of the infectious disease diagnostics market provides detailed qualitative and quantitative insights about the five major geographies (North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa) along with the coverage of major countries in each region. North America region is estimated to command the largest share of the global infectious disease diagnostics market in 2020, followed by Europe, Asia-Pacific, Latin America, and the Middle East & Africa. However, Asia Pacific region is slated to register the highest growth during the forecast period primarily due to the rapid urbanization, increasing investments by healthcare providers towards infrastructure improvement, need to manage growing burden of infectious diseases, and government efforts to improve the accessibility of diagnostic services to enhance the prevention by developing products or platforms required for the diagnosis of infectious diseases.
The key players operating in the global infectious disease diagnostics market are Abbott Laboratories (U.S.), Danaher Corporation (U.S.), Bio-Rad Laboratories, Inc. (U.S.), bioMerieux S.A. (France), Thermo Fisher Scientific (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), Becton, Dickinson and Company (U.S.), DiaSorin S.p.A. (Italy), Meridian Bioscience Inc. (U.S.), and Quidel Corporation (U.S.) among others.
Other Technologies comprises of microscopy, hybridization, and loop-mediated isothermal amplification
Other diseases comprise of measles, small pox, mumps, typhoid fever, malaria, meningitis, Ebola virus disease, Lyme disease, coronavirus disease, and whooping cough.
Other end users comprise of physician offices, nursing facilities, and home healthcare agencies
"1. Introduction
Healthcare-associated Infectious Disease Diagnostics Market Research Report by Product & Service, by Disease Type, by End-user - Global Forecast to 2025 - Cumulative Impact of COVID-19
Infectious Disease Diagnostics
Infectious Disease Diagnostics Market - Growth, Trends, and Forecasts (2020 - 2025)
Infectious Disease Diagnostics - Global Market Outlook (2018-2027)
OTC/DTC Infectious Disease Diagnostics Strategies and Trends. Covid-19 Adjusted Forecasts by Application by Channel by Country. With Market Analysis, Executive Guides, Customization and Covid-19 Market Opportunity Analysis. 2020 to 2024
Infectious Disease Diagnostics: World Market Analysis: HIV/AIDS, Hepatitis, Tuberculosis, STDs, HAIs, ID/AST, Influenza, TORCH, Other
Infectious Disease Diagnostics Market - Size, Share, Trends, and Forecast to 2026
Infectious Disease Diagnostics Market by Product & Service (Assay, Kit & Reagent, Instruments), Disease Type (Hepatitis, HIV, HAI, HPV, TB, Influenza), Technology (Immunodiagnostics, PCR, NGS), End User - Global Forecast to 2022
Global Infectious Disease Diagnostics Market Forecast 2017-2027: Revenue Prospects by Disease Type (HIV/AIDS, Hepatitis, Tuberculosis, Malaria, Chlamydia), Technique, End User and Geography
